drug

BHV-1300

1 story · latest Aug 10, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Biohaven Ltd.

Timeline

Biohaven advances degrader and epilepsy pipelines, reports Q2 2026 results

Aug 10Quarterly updateBHV-1300 Biohaven Ltd.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.